Indaptus appoints Walt Linscott as COO; sets 2023 annual meeting for May 25

Indaptus Therapeutics, Inc.

Walt Linscott, previously Chief Business Officer, appointed COO effective March 22, 2023.
Robert Martell, M.D., Ph.D. appointed to Board's Science and Technology Committee.
Annual meeting set for May 25, 2023; stockholder proposals due by April 2, 2023.

item 5.02 item 8.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Walt A. Linscott

Chief Operating Officer

INDP · Indaptus Therapeutics, Inc.

Effective: 2023-03-22
Filed: March 23, 2023, 7:59 PM ET

On March 22, 2023, the Board appointed Walt A. Linscott, the Company's Chief Business Officer, as the Company's Chief Operating Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Walt A. Linscott was appointed as Chief Operating Officer at Indaptus Therapeutics, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On March 22, 2023, the Board appointed Walt A. Linscott, the Company's Chief Business Officer, as the Company's Chief Operating Officer, effective immediately.

View on SEC.gov

Indaptus Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-008636

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.